0001161697-22-000606.txt : 20221229
0001161697-22-000606.hdr.sgml : 20221229
20221229164755
ACCESSION NUMBER: 0001161697-22-000606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221227
FILED AS OF DATE: 20221229
DATE AS OF CHANGE: 20221229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harper Molly
CENTRAL INDEX KEY: 0001871470
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 221499317
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form_4.xml
FORM 4 FOR 12-27-2022
X0306
4
2022-12-27
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001871470
Harper Molly
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
1
0
0
0
Options to purchase common stock
18.59
2022-12-27
4
A
0
15000
0
A
2029-12-27
Common Stock
15000
107000
D
Restricted Stock Units
2022-12-27
4
A
0
4000
0
A
Common Stock
4000
111000
D
Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025.
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Shares of common stock will be delivered to the Reporting Person upon vesting.
/s/ Molly Harper
2022-12-29